ENDING NEGLECTED DISEASES: A ROADMAP TO SUCCESS
2006 – The Legatum Foundation commits US$ 8.9 million to combat NTDs in Rwanda and Burundi using two new concepts of treatment delivery.
2007 – Programmes get underway in Rwanda and Burundi.
2008 – Encouraged by success, the Legatum Foundation begins research programme on expanding to other countries in Africa.
2009 – Conversations begin with partners in the NTD space about forming a private philanthropic fund with donors as co-funders, catalysts, and decision makers.
2010 – The END Fund concept is developed, with the Legatum Foundation acting as anchor donor.
2011 – The END Fund becomes an independent legal entity, registered in the US and UK. Geneva Global is appointed to serve as charity administrator and grant manager. International and technical advisory boards formed. Fundraising commences.
January 2012 – London Declaration. WHO publishes a roadmap to overcome the impact of NTDs by 2020.
April 2012 – Ellen Agler is appointed as CEO of The END Fund.
June 2012 – Official launch of The END Fund.
October 2012 – The END Fund responds to an urgent funding need in Mali to ensure medicines are delivered to millions of people throughout the country.
2014 – The END Fund impacts over 75 million people since its launch.
2015 - The END Fund, alongside the Children’s Investment Fund Foundation, the UK aid agency DFID, and a range of other private donors, partner with The Ethiopian Federal Ministry of Health (FMOH) to launch their National School-Based Deworming Programme to treat 16.5 million children.
2016 - The END Fund treats over 100 million people in 2016 through mass drug administration initiatives.
The END Fund is the world's first private philanthropic initiative
to combat the five most common NTDs that, together, cause
up to 90 percent of the NTD burden. Supported
by a group of global philanthropists, The END Fund provides
financing for nationwide disease control initiatives, creating new
programmes, supplementing existing ones, and using matching
funds to extend and deepen the impact.
The END Fund was founded in 2012 with a goal of reaching 100 million people and the control or eradication of the most prevalent NTDs in the world. In its first year the Fund mobilised over US$ 18 million, reaching 15 million people in Rwanda, Burundi, Zambia, Namibia and Mali.
In Mali the bilateral donors were forced to pull out due to the restrictions placed upon them by their governments, which left a programme that had already treated 11 million people facing cancellation. Ellen Agler, the CEO of the END Fund, was able to build a consortium of private donors consisting of foundations, individuals and corporations that were able to rise to the challenge and step forward where governments had been forced to step back. The result was the continuation of the programme and improved health for many millions of people.
The Fund is chaired by Bill Campbell whose family Foundation were key early investors in the initiative. For more information about the END Fund, please go to www.END.org.
Neglected tropical diseases inflict suffering and chronic disability on
1.4 billion of the world's most impoverished and marginalised people. 500 million of these
are children. They cause pain, illness and even death, but they also keep
children out of school, and rob people of their productivity.